333 | Hope to see it at least tomorrow, it will boost | Milly Joel | 10/10/2012 3:46:09 PM |
332 | Looking | mwirmm | 10/10/2012 3:40:08 PM |
331 | Some PR | mwirmm | 10/10/2012 3:35:37 PM |
330 | Glad yo | mwirmm | 10/10/2012 3:26:38 PM |
329 | Theyre | mwirmm | 10/10/2012 3:19:27 PM |
328 | No doub | mwirmm | 10/10/2012 3:17:47 PM |
327 | Forex companies a | judith keenan | 10/10/2012 1:16:39 PM |
326 | Time to | judith keenan | 10/10/2012 1:07:35 PM |
325 | UWRL is | John Howard | 10/10/2012 1:01:40 PM |
324 | This company could be a huge long term play but | judith keenan | 10/10/2012 1:00:35 PM |
323 | UWRL ha | John Howard | 10/10/2012 12:51:44 PM |
322 | UWRL was very nice | judith keenan | 10/10/2012 12:42:10 PM |
321 | Definit | judith keenan | 10/10/2012 11:12:57 AM |
320 | UWRL al | theellasmith | 10/10/2012 10:40:00 AM |
319 | All the | theellasmith | 10/10/2012 10:36:50 AM |
318 | UWRL - some action | theellasmith | 10/10/2012 10:33:58 AM |
317 | UWRL - | theellasmith | 10/10/2012 10:29:43 AM |
316 | With MA | Mary Johnson | 10/10/2012 8:25:37 AM |
315 | You are | Mary Johnson | 10/10/2012 8:17:18 AM |
314 | You are | Mary Johnson | 10/10/2012 8:13:46 AM |
313 | Enter in a long play whit UWRL | Mary Johnson | 10/10/2012 8:10:50 AM |
312 | Moving forward | Mary Johnson | 10/10/2012 8:06:34 AM |
311 | ExpotentialMovingAverage and | aleksdavis | 10/10/2012 7:35:54 AM |
310 | When we | aleksdavis | 10/10/2012 7:30:35 AM |
309 | EMA and | aleksdavis | 10/10/2012 7:05:56 AM |
308 | Now is | aleksdavis | 10/10/2012 6:57:33 AM |
307 | Also, | aleksdavis | 10/10/2012 6:50:19 AM |
306 | Looking | mwirmm | 10/09/2012 2:37:10 PM |
305 | UWRL lo | mwirmm | 10/09/2012 2:36:13 PM |
304 | UWRL Ti | mwirmm | 10/09/2012 2:34:55 PM |
303 | keep an eye on it within a couple of | judith keenan | 10/09/2012 2:03:34 PM |
302 | I would buy in this gap if iwasn'talready in | judith keenan | 10/09/2012 1:55:58 PM |
301 | UWRL can be very good play too if | judith keenan | 10/09/2012 12:03:45 PM |
300 | UWRL going up Chart pattern clearly indicates | John Howard | 10/09/2012 12:03:31 PM |
299 | BUYsig | John Howard | 10/09/2012 11:52:51 AM |
298 | UWRL Maximum BUY | John Howard | 10/09/2012 11:38:15 AM |
297 | Conclus | Mary Johnson | 10/09/2012 5:32:51 AM |
296 | You are | Mary Johnson | 10/09/2012 5:25:21 AM |
295 | Any upd | aleksdavis | 10/09/2012 5:02:08 AM |
294 | This is | aleksdavis | 10/09/2012 4:31:20 AM |
293 | 20 - 50 Day MACD Oscillator Buy 20-50 Day MACD | aleksdavis | 10/09/2012 4:24:16 AM |
292 | Im sure | aleksdavis | 10/09/2012 4:18:30 AM |
291 | Price i | aleksdavis | 10/09/2012 4:11:51 AM |
290 | UWRL wi | theellasmith | 10/09/2012 4:05:31 AM |
289 | You are | Mary Johnson | 10/09/2012 4:00:58 AM |
288 | I've se | theellasmith | 10/09/2012 3:55:20 AM |
287 | To find | theellasmith | 10/09/2012 3:51:50 AM |
286 | These a | theellasmith | 10/09/2012 3:47:33 AM |
285 | I prefe | Mary Johnson | 10/09/2012 3:40:33 AM |
284 | Short,medium or long run?However success is | Mary Johnson | 10/09/2012 3:16:00 AM |
Recent Articles
- AutoShop Answers Reveals Exciting 2026 Training Calendar Plans
- First American Uranium Closes Private Placement, Expanding Operations
- How Digital Realty Trust Delivered Exceptional Returns Over Time
- Acceleware Ltd. Expands Private Placement Financing Timeline
- Understanding Dow Inc.'s Legal Challenges and Stock Performance
- Understanding the Indulgence of Investing in Energy Transfer
- Zenvia Announces Fiscal Q2 2025 Earnings Release Schedule
- Alzheimer's Association Supports New Leqembi Dosing Approval
- Investors May Pursue Class Action Against Encompass Health
- Acceleware Ltd. Expands Financing Options for Growth
- Investing in Laureate Education: A 5-Year Journey to Wealth
- FDA Approves New Autoinjector for Alzheimer's Treatment
- FDA Greenlights Leqembi for Alzheimer's Maintenance Therapy
- Beijing: Blending Cultural Heritage with Modern Innovation
- Sanofi's Groundbreaking Decision for Wayrilz in the US Market
- Ocean Tides Launches Holiday Gift Wrap Multipacks on Walmart
- Understanding Knight-Swift Inc's Earnings and Market Position
- Asbestos Corporation Limited Advances Restructuring Efforts
- Rock Tech Lithium Secures $7.5 Million Investment through Offerings
- Investors Unite on Semler Scientific Securities Class Action
- Rock Tech Lithium Secures Up to $7.5 Million Fundraising
- Sword Group's 2025 Liquidity Overview with ODDO BHF
- Sanofi's Wayrilz Revolutionizes Treatment for Immune Thrombocytopenia
- Sword Group Unveils 2025 Financial Report for Investors
- Transforming $1000 Into $14,836: Ameriprise Financial's Growth
- Bravo Mining Corp. Adjusts 2024 Financial Statements After Restatement
- First Nordic Metals Reports Strong Q2 2025 Results
- Investors Prepare to Navigate Luminar Technologies Lawsuit
- Investors Stepping Forward in Spectrum Pharmaceuticals Lawsuit
- Centrus Energy Announces Participation in Key Investor Conferences
- California Energy Commission's Decision Leaves Gas Prices Unchecked
- Dr. Colleen Cowdery Strengthens Expertise at Washington Poison Center
- Immunovant Faces Investigation by Kahn Swick & Foti Law Firm
- Tamarack Resort Highlights Growth and Fire Mitigation Efforts
- Legal Inquiry into Apple Management: Key Developments Ahead
- Northland Power Reveals New Dividend Rates for Preferred Shares
- Amazing Growth: A $100 Investment in Guidewire Today
- Investors Take Action Against Semler Scientific, Inc. for Fraud
- Lundin Gold Reports Share Capital Changes and Growth Prospects
- Biomerica's Year-End Financial Review: Key Achievements and Insights
- Understanding the Semler Scientific Class Action Lawsuit Risk
- Strategic Leadership Changes at FIELDBOSS to Drive Growth
- Northland Power Unveils New Dividend Rates for Shareholders
- Anoto Group's Mid-Year Results: Key Insights and Developments
- Newcore Gold Unveils Annual Equity Incentive Awards Program
- Biomerica’s Fiscal 2025 Results: Resilient Performance Amid Challenges
- Newcore Gold's Exciting Annual Equity Incentive Award Announcement
- Understanding Shift4 Payments Inc. Financial Landscape Today
- Investing $100 in Hancock Whitney: Surprising Returns Explained
- Investing Insights: Suze Orman and Jim Cramer on Quantum Stocks